Head-To-Head Review: FONAR (NASDAQ:FONR) & Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLRGet Free Report) and FONAR (NASDAQ:FONRGet Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.

Risk & Volatility

Semler Scientific has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. Comparatively, FONAR has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Semler Scientific and FONAR, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific 0 0 0 1 4.00
FONAR 0 0 0 0 N/A

Earnings and Valuation

This table compares Semler Scientific and FONAR’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Semler Scientific $68.18 million 3.59 $20.58 million $2.79 12.42
FONAR $98.64 million 0.98 $9.38 million $1.56 9.74

Semler Scientific has higher earnings, but lower revenue than FONAR. FONAR is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 13.0% of Semler Scientific shares are held by company insiders. Comparatively, 2.2% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.


This table compares Semler Scientific and FONAR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Semler Scientific 32.92% 30.36% 27.38%
FONAR 10.66% 7.10% 5.39%


Semler Scientific beats FONAR on 9 of the 12 factors compared between the two stocks.

About Semler Scientific

(Get Free Report)

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.


(Get Free Report)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.